Update on BioChem Pharma / Shire Pharmaceutical Merger

27-Apr-2001

BioChem Pharma Inc. ("BioChem") (NASDAQ: BCHE; TSE: BCH) announces that Shire Pharmaceuticals Group plc ("Shire") issued the following statement earlier today updating the timetable for its proposed merger with BioChem.

"In respect to the proposed merger with BioChem Pharma Inc., although the current review period with Industry Canada expires on 27 April 2001, Shire requested an extension on 25 April 2001.

Discussions with Industry Canada are ongoing and Shire remains firmly committed to obtaining the Canadian Minister of Industry's approval for the proposed merger with BioChem Pharma Inc."

BioChem remains fully supportive of the transaction and committed to use all efforts to assist Shire in obtaining the approval of the Minister of Industry.

On December 10, 2000, BioChem entered into an agreement to merge with Shire to form a leading global specialty pharmaceutical company. More details on this proposed merger and other aspects of the company are available on the BioChem website.

Other news from the department

Most read news

More news from our other portals

Discover the latest developments in battery technology!